Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
Clinical trial NCT00436553 · COMPLETED
Trial details
- NCT number
- NCT00436553
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.